Fact-checked by Grok 2 weeks ago

Perfusion

Perfusion is the passage of bodily fluids, such as blood, through the circulatory or lymphatic system to an organ or tissue, ensuring the supply of oxygen and nutrients while facilitating the removal of metabolic waste products.^[1] This fundamental biological function is essential for maintaining cellular homeostasis and is quantified as the rate of blood flow per unit of tissue mass, typically expressed in milliliters per minute per 100 grams of tissue.^[2] Inadequate perfusion, known as hypoperfusion, can lead to tissue ischemia and organ dysfunction, whereas hyperperfusion may cause edema or hemorrhage, underscoring its critical role in health and disease.^[3] In clinical medicine, perfusion extends beyond natural physiology to include diagnostic and therapeutic applications. Perfusion imaging techniques, such as magnetic resonance perfusion^[4] and nuclear scintigraphy,^[5] are used to assess blood flow in organs like the brain, heart, and lungs, aiding in the diagnosis of conditions including stroke, coronary artery disease, and pulmonary embolism. Therapeutically, extracorporeal perfusion systems, operated by cardiovascular perfusionists, temporarily take over the heart and lungs' functions during open-heart surgery by circulating oxygenated blood through an external circuit.^[1] Machine perfusion is also employed in organ transplantation to preserve donor organs ex vivo under controlled conditions, improving viability and expanding the donor pool.^[6] The study and management of perfusion involve multidisciplinary approaches, integrating principles from physiology, radiology, and surgery. Factors influencing perfusion include cardiac output, vascular resistance, and gravitational effects, with regional variations often assessed via the ventilation-perfusion ratio in the lungs to optimize gas exchange.^[7] Advances in perfusion technology continue to evolve, particularly in critical care settings like sepsis and trauma, where monitoring tools such as near-infrared spectroscopy provide real-time insights into tissue oxygenation.^[8]

Fundamentals

Definition

Perfusion is a physiological process involving the passage of blood or other fluids through the circulatory system to deliver oxygen, nutrients, and hormones to tissues while facilitating the removal of metabolic waste products such as carbon dioxide and lactate. The term derives from the Latin perfusio, meaning "a pouring through" or "to pour over," reflecting the concept of fluid permeating a structure. In medical and physiological contexts, perfusion specifically refers to the bulk flow of blood through capillaries and microvasculature, ensuring adequate supply to meet tissue demands.^[9]^[10]^[11] A key distinction exists between perfusion and diffusion: perfusion entails the convective, pressure-driven bulk movement of blood within vessels to reach tissue beds, whereas diffusion is the passive molecular transport across membranes driven by concentration gradients, such as the exchange of oxygen from erythrocytes to parenchymal cells. This separation underscores perfusion's role in macroscopic delivery and diffusion's in microscopic transfer. Perfusion is quantified as the rate of blood flow per unit tissue mass or volume, often denoted as Q, calculated simply as Q = \frac{\text{[blood](/page/Blood+) flow}}{\text{[tissue](/page/Tissue) [mass](/page/Mass)}}. Common units include milliliters per minute per gram (mL/min/g) of tissue, accounting for variations in tissue density.^[12]^[10]^[11] For example, in a resting adult with a cardiac output of approximately 5 L/min, perfusion varies by organ to match metabolic needs; the kidneys, for instance, receive about 20% of total cardiac output, yielding a perfusion rate of roughly 3–4 mL/min/g to support glomerular filtration. Such distribution highlights perfusion's adaptive nature in maintaining organ homeostasis.^[13]^[14]^[15]

Physiological Role

Perfusion plays a critical role in delivering oxygen and essential nutrients to tissues, enabling aerobic metabolism and sustaining cellular function. Through the circulatory system, blood flow transports oxygen bound to hemoglobin and dissolved nutrients such as glucose directly to capillary beds, where they diffuse into interstitial spaces and cells to support energy production via oxidative phosphorylation.^[16] This process is quantified by the Fick principle, which states that oxygen consumption (VO₂) equals cardiac output or perfusion rate (Q) multiplied by the arterial-venous oxygen content difference (VO₂ = Q × (CaO₂ - CvO₂)), highlighting how perfusion rate directly influences tissue oxygenation.^[17] Beyond nutrient supply, perfusion facilitates the removal of metabolic waste products, including carbon dioxide (CO₂) and lactate, preventing accumulation that could lead to acidosis and cellular dysfunction. Blood flow carries these byproducts from tissues back to the lungs for CO₂ exhalation or to the liver and kidneys for lactate processing, maintaining acid-base balance.^[18] Additionally, perfusion contributes to thermoregulation by distributing heat generated in metabolically active organs to the skin and periphery, where vasodilation or constriction modulates heat loss through convection and radiation to stabilize core body temperature.^[18] Perfusion demands vary by organ to match metabolic requirements, with autoregulation ensuring stable blood flow despite fluctuations in systemic pressure. For instance, the brain receives approximately 750 mL/min to support high oxygen needs for neuronal activity, while the kidneys get about 1000 mL/min to facilitate filtration and reabsorption.^[19]^[20] This targeted distribution underscores perfusion's role in preserving organ-specific homeostasis. In the lungs, perfusion integrates with ventilation to optimize gas exchange, as described by the ventilation-perfusion (V/Q) ratio, ideally near 0.8 overall, which balances alveolar air flow (V) with capillary blood flow (Q) to maximize oxygen uptake and CO₂ elimination.^[7]

Historical Development

Early Concepts

The foundational concepts of perfusion emerged from ancient observations of blood flow, with the Roman physician Galen (c. 129–c. 200 AD) proposing that blood originated in the liver and was distributed centrifugally through the venous system to nourish peripheral tissues, a view that emphasized blood's role in vital processes without recognizing a closed circulatory loop.^[21] This theory persisted through the Middle Ages, influencing early understandings of how blood reached organs and muscles, though it lacked empirical validation of directional flow dynamics essential to perfusion.^[22] During the Renaissance, William Harvey revolutionized these ideas with his 1628 publication De Motu Cordis et Sanguinis in Animalibus, where he demonstrated through quantitative dissections and vivisections that blood circulates continuously in a closed system propelled by the heart, providing the mechanistic basis for perfusion as the targeted delivery of arterial blood to tissues for oxygenation and nutrient exchange.^[23] Harvey's work shifted focus from static distribution to dynamic flow, highlighting the heart's pumping action as central to maintaining tissue viability, though direct measurement of local perfusion remained elusive. Building on this, Marcello Malpighi observed capillaries in the lung of a frog in 1661, providing the first microscopic evidence of blood flow through the microvasculature and completing the circulatory loop at the tissue level.^[24] The 19th century brought experimental rigor to perfusion studies, exemplified by Claude Bernard's investigations in the early 1850s, which revealed vasomotor nerves' control over blood vessel tone; by sectioning the cervical sympathetic nerve in 1851, Bernard observed vasodilation and increased local blood flow in the ear of rabbits, establishing neural regulation as a key mechanism for adapting perfusion to environmental or metabolic demands.^[25] These findings underscored perfusion's responsiveness, linking it to homeostasis rather than mere circulation.^[26] Pioneering animal experiments further illuminated perfusion at the tissue level, with researchers in the 1800s injecting colored dyes—such as carmine or indigo solutions—into the vascular systems of frogs and mammals to trace capillary pathways and assess flow distribution under the microscope, often in transparent tissues like frog mesentery or tongue.^[27] These methods allowed visualization of blood's passage through microvasculature, confirming Harvey's circulatory model at the peripheral scale and revealing perfusion gradients influenced by vessel diameter and pressure.^[28] A pivotal enabler was the 1846 public demonstration of ether anesthesia by William T.G. Morton, which permitted prolonged surgical and observational studies of blood flow in intact animals without distress, facilitating detailed intraoperative assessments of tissue perfusion.^[29] In 1895, Oscar Langendorff developed the isolated perfused heart preparation, allowing controlled study of coronary blood flow and cardiac function ex vivo in mammalian hearts.^[30]

Key Advancements

One of the most transformative advancements in perfusion technology occurred in 1953 when John H. Gibbon Jr. invented the cardiopulmonary bypass machine, which facilitated the first successful open-heart surgery by providing controlled extracorporeal perfusion to oxygenate blood and maintain circulation during procedures that temporarily halt the heart.^[31] This innovation revolutionized cardiac surgery, enabling complex interventions previously impossible due to the need for uninterrupted blood flow and oxygenation.^[32] In the 1960s, studies on microcirculation advanced significantly through electron microscopy techniques pioneered by Guido Majno and George E. Palade, who elucidated key capillary dynamics, particularly how histamine and serotonin induce endothelial contraction to increase vascular permeability during inflammation. Their work provided foundational insights into the ultrastructural mechanisms governing nutrient and oxygen delivery at the tissue level, influencing subsequent research on microvascular function and pathology. The 1970s marked the introduction of computed tomography (CT) as a pioneering tool for quantitative perfusion assessment, with early CT perfusion techniques emerging in 1979 to measure cerebral blood flow dynamics via contrast-enhanced sequential scans.^[33] Magnetic resonance imaging (MRI), also developed in the 1970s, enabled non-invasive perfusion assessment starting in the 1990s. These modalities shifted perfusion evaluation from invasive methods to non-invasive imaging, allowing precise mapping of regional blood flow and volume in clinical settings like stroke diagnosis.^[34] Advancements in the 2000s and 2010s focused on isolated organ perfusion for transplantation, notably normothermic machine perfusion (NMP), which maintains organs at body temperature with oxygenated blood to mitigate ischemia-reperfusion injury; the first successful clinical applications in liver transplantation occurred in 2016, demonstrating improved graft viability and expanded donor pools.^[35] This technique has since reduced post-transplant complications by allowing real-time organ assessment and resuscitation, particularly for marginal donors.^[35]

Physiology

Microcirculatory Processes

Capillaries serve as the primary site of nutrient and gas exchange in the microcirculation, consisting of a single layer of endothelial cells surrounded by a basement membrane. Endothelial cells form a thin, continuous barrier that regulates the passage of molecules and cells between the bloodstream and tissues, adapting to local physiological demands through processes like angiogenesis. The basement membrane, composed of extracellular matrix proteins such as laminin and collagen IV, provides structural support and acts as a selective filter, influencing permeability and maintaining vascular integrity during perfusion.^[36] Fluid exchange across the capillary wall is governed by Starling forces, which balance hydrostatic and oncotic pressures to determine net filtration or absorption. Hydrostatic pressure within the capillary (Pc) drives fluid outward, while interstitial hydrostatic pressure (Pi) opposes it; conversely, oncotic pressures (πc in plasma and πi in interstitium) due to plasma proteins promote fluid retention. This dynamic is quantified by the Starling equation:

J_v = K_f \left[ (P_c - P_i) - \sigma (\pi_c - \pi_i) \right]

where J_v is the transendothelial fluid flow rate, K_f is the filtration coefficient reflecting capillary permeability and surface area, and \sigma is the reflection coefficient indicating solute permeability. In continuous capillaries, such as those in muscle, this mechanism ensures controlled exchange, with net filtration at the arterial end and absorption at the venular end, preventing excessive fluid loss.^[37] Arterioles and venules contribute to microcirculatory perfusion by modulating capillary recruitment and flow distribution. Precapillary sphincters, located at the junction of terminal arterioles and capillaries, act as gatekeepers that open or close in response to local metabolic signals, thereby regulating the number of perfused capillaries and optimizing oxygen delivery. These sphincters relax in the presence of vasodilatory metabolites like adenosine, which accumulates during tissue hypoxia or increased metabolic activity, and nitric oxide (NO), produced by endothelial cells in response to shear stress, enhancing vasodilation and blood flow. This local control ensures that perfusion matches tissue demand without relying on broader systemic adjustments.^[38] Tissue perfusion exhibits significant heterogeneity across organs and within zonal structures, reflecting adaptations to specific functional needs. In the liver, sinusoids—specialized discontinuous capillaries—feature fenestrated endothelial cells with pores (100–200 nm) grouped in sieve plates, lacking a continuous basement membrane, which allows direct exchange between blood and hepatocytes in the space of Disse. This structure results in zonal variations, with higher porosity (up to 8%) in centrilobular regions compared to periportal zones (around 6%), facilitating nutrient uptake from dual blood supplies but introducing variable flow velocities (400–450 μm/s). In contrast, skeletal muscle capillaries have continuous endothelium with tight junctions and a prominent basement membrane, promoting uniform diffusion over short distances (about 1 μm to fibers) at higher velocities (500–1,000 μm/s), prioritizing efficient oxygen delivery during contraction. Such differences underscore how microvascular architecture tailors perfusion to organ-specific roles, from filtration in the liver to metabolic support in muscle.^[39]^[40] The endothelial glycocalyx, a gel-like layer coating the luminal surface of capillary endothelial cells, further refines perfusion by serving as a protective barrier against excessive fluid and solute leakage. Composed primarily of proteoglycans (e.g., syndecans and glypicans bearing glycosaminoglycan chains like heparan sulfate, comprising 50–90% of the structure) and glycoproteins (e.g., selectins and integrins with branched carbohydrate moieties), the glycocalyx extends 0.2–0.5 μm into the lumen, creating an exclusion zone for red blood cells and modulating permeability through charge and steric effects. This composition enables selective transport, repelling larger molecules while permitting small solutes, thus maintaining vascular homeostasis and preventing edema during normal perfusion.^[41]

Regulation Mechanisms

Perfusion in tissues is tightly regulated by a combination of intrinsic and extrinsic mechanisms to ensure adequate oxygen and nutrient delivery while matching metabolic demands. These controls operate at local, neural, hormonal, and endothelial levels, maintaining stable blood flow despite fluctuations in systemic pressure or tissue activity. Intrinsic autoregulation, for instance, allows vascular beds to adjust resistance independently of central influences, primarily through myogenic and metabolic pathways. Autoregulation is a fundamental intrinsic mechanism that stabilizes tissue perfusion across a range of perfusion pressures, typically between 60 and 160 mmHg in many organs. The myogenic response involves vascular smooth muscle contraction in response to increased intraluminal pressure, which stretches the vessel wall and triggers depolarization via mechanosensitive ion channels, thereby increasing resistance to prevent excessive flow. Complementing this, metabolic feedback adjusts perfusion based on tissue oxygen and metabolite levels; for example, hypoxia induces vasodilation through the hypoxia-inducible factor 1α (HIF-1α) pathway, which upregulates genes for nitric oxide synthase and adenosine production, enhancing blood flow to hypoxic regions. These processes ensure that cerebral and renal perfusion, among others, remains constant during moderate pressure changes. Neural control provides extrinsic modulation, predominantly via the autonomic nervous system, to redistribute perfusion during systemic needs like exercise or stress. Sympathetic activation causes vasoconstriction in most vascular beds through α-adrenergic receptors on smooth muscle, releasing norepinephrine that binds to these G-protein-coupled receptors, elevating intracellular calcium and promoting contraction; this diverts blood from splanchnic and cutaneous areas to muscles and vital organs. In contrast, parasympathetic innervation, though limited to specific beds like coronary and cerebral vessels, induces dilation via muscarinic receptors that stimulate nitric oxide release from endothelium, increasing flow during rest or digestion. Hormonal influences further fine-tune perfusion on a longer timescale, integrating signals from the renin-angiotensin-aldosterone system and cardiac peptides. Angiotensin II, produced in response to low renal perfusion, acts as a potent vasoconstrictor by binding AT1 receptors on vascular smooth muscle, initiating phospholipase C-mediated calcium signaling that enhances resistance and maintains systemic pressure. Conversely, atrial natriuretic peptide (ANP), secreted by atrial myocytes during volume expansion, promotes vasodilation by activating guanylate cyclase receptors, increasing cyclic GMP to relax smooth muscle and reduce afterload, thereby improving cardiac output and tissue perfusion. Endothelial cells serve as a dynamic interface for local regulation, sensing hemodynamic forces and releasing vasoactive substances. Shear stress from increased blood flow activates mechanosensors like PECAM-1 and VEGFR2, leading to phosphorylation cascades that stimulate endothelial nitric oxide synthase (eNOS) to produce nitric oxide (NO), which diffuses to smooth muscle to induce relaxation and flow-mediated dilation. This mechanism is crucial for matching perfusion to increased metabolic demand, such as in exercising skeletal muscle, where sustained shear promotes sustained vasodilation. The relationship between perfusion pressure, flow, and resistance is mathematically described by Poiseuille's law, which models laminar flow in rigid tubes and underscores how vascular radius dominates resistance. The resistance R to flow is given by

R = \frac{8 \eta L}{\pi r^4}

where \eta is blood viscosity, L is vessel length, and r is radius; thus, flow Q = \Delta P / R (analogous to Ohm's law) highlights that small changes in radius profoundly affect perfusion, linking regulatory mechanisms to pressure-flow dynamics.

Pathophysiology

Malperfusion

Malperfusion refers to inadequate blood flow through a blood vessel, resulting in cellular or organ injury, inadequate oxygenation, infarction, or necrosis.^[42] It arises from a mismatch between tissue perfusion supply and metabolic demand, leading to ischemia when oxygen delivery falls below requirements for aerobic metabolism.^[43] Malperfusion can be classified as global or regional, and as acute or chronic. Global malperfusion involves widespread systemic hypoperfusion, such as in hypovolemic or cardiogenic shock, where overall cardiac output fails to meet bodily demands.^[44] Regional malperfusion affects specific vascular territories, for example, due to arterial embolism obstructing localized blood supply.^[45] Acute forms develop rapidly, often within minutes, as in thromboembolic events, while chronic malperfusion evolves gradually, as seen in progressive atherosclerotic narrowing.^[46] At the cellular level, malperfusion triggers rapid ATP depletion due to halted oxidative phosphorylation and reliance on anaerobic glycolysis. This shift causes accumulation of lactic acid, resulting in intracellular acidosis and impaired enzyme function. Prolonged ischemia leads to irreversible necrosis, with timelines varying by tissue. In the brain, vulnerable neurons like those in the hippocampus can suffer irreversible damage within 5 minutes of complete ischemia, while the myocardium typically withstands 20-40 minutes before necrosis ensues, as membrane integrity fails and ion pumps cease.^[47]^[48] Diagnostic indicators of malperfusion include elevated tissue or venous lactate levels exceeding 2 mmol/L, signaling anaerobic metabolism from hypoperfusion, and tissue pH below 7.2, reflecting severe acidosis.^[49] These markers help identify ischemic states but require correlation with clinical context. Malperfusion represents one end of a perfusion spectrum; the opposite extreme includes hyperperfusion syndromes, where abrupt restoration of flow to chronically hypoperfused tissues causes endothelial dysfunction, edema, and hemorrhage due to impaired autoregulation.^[50]

Causes and Consequences

Perfusion deficits frequently originate from vascular pathologies that compromise arterial integrity and blood flow. Atherosclerosis, the progressive accumulation of lipid-rich plaques within arterial walls, narrows lumens and reduces downstream perfusion, particularly affecting high-demand organs like the heart and brain.^[51] Vasospasm, involving abrupt and intense contraction of vascular smooth muscle, transiently occludes vessels and induces localized ischemia, as seen in coronary vasospastic angina where endothelial dysfunction exacerbates the response.^[52] Thromboembolism, the embolization of thrombi from proximal sites, acutely blocks distal vasculature; a prominent example is carotid artery occlusion leading to cerebral hypoperfusion and ischemic stroke, where clot propagation halts oxygen delivery to hemispheric territories.^[53] Cardiac sources of perfusion impairment stem from conditions that curtail effective blood ejection. In heart failure with reduced ejection fraction—defined as less than 40%—myocardial dysfunction diminishes stroke volume and overall cardiac output, resulting in systemic underperfusion and tissue hypoxia.^[13] This output deficit activates compensatory mechanisms like neurohormonal surges but ultimately fails to maintain adequate organ-level blood flow, perpetuating a cycle of worsening ischemia.^[54] Systemic etiologies further contribute to global hypoperfusion through volume or distribution imbalances. Hypovolemia, commonly induced by acute hemorrhage, depletes intravascular volume and reduces venous return, thereby lowering cardiac preload and tissue oxygenation.^[55] Sepsis-driven distributive shock, characterized by cytokine-mediated vasodilation and capillary leak, creates a relative hypovolemic state with maldistributed flow, severely limiting microvascular perfusion despite normal or elevated cardiac output.^[56] The repercussions of sustained perfusion deficits manifest as multi-organ dysfunction syndrome (MODS), a progressive cascade where initial hypoperfusion induces cellular energy failure, inflammation, and sequential organ involvement.^[57] Critical timelines underscore the urgency: in the brain, complete ischemia triggers irreversible neuronal death in vulnerable regions like the hippocampus within 5 minutes, escalating to widespread infarction by 10–20 minutes.^[48] MODS often evolves from such hypoxic insults, compounded by endothelial damage and microvascular thrombosis, leading to renal, hepatic, and pulmonary failures if uncorrected.^[58] Restoration of perfusion, while essential, can provoke reperfusion injury, wherein reintroduction of oxygen generates cytotoxic free radicals through pathways like xanthine oxidase conversion of hypoxanthine to uric acid.^[59] This oxidative burst amplifies tissue necrosis, endothelial dysfunction, and inflammatory mediator release, paradoxically extending damage beyond the initial ischemic period in organs such as the myocardium and kidneys.^[60]

Measurement Techniques

Microsphere Methods

The microsphere method is an invasive technique used to quantify regional tissue perfusion by injecting microspheres into the arterial circulation, where they become trapped in the microvasculature in proportion to blood flow. Typically, microspheres ranging from 15 to 50 μm in diameter, often radiolabeled with isotopes such as ^{141}Ce, ^{85}Sr, or ^{46}Sc, are suspended in a carrier solution and injected directly into the left atrium, left ventricle, or a major artery to ensure uniform mixing with the bloodstream.^[61] Once circulated, these microspheres lodge in precapillary arterioles and capillaries, with their distribution reflecting local perfusion rates; particles smaller than 10 μm may pass through some beds, while larger ones (up to 50 μm) provide better retention but risk partial shunting in high-flow organs like the lungs or kidneys.^[62] Following injection, a reference arterial blood sample is withdrawn at a known rate (typically 5-10 mL/min) from a peripheral artery, such as the femoral, to normalize measurements against total cardiac output.^[61] Perfusion is calculated using the ratio of microspheres recovered in a tissue sample to those in the reference sample, scaled by the withdrawal rate. The formula for regional blood flow Q (in mL/min/g) is:

Q = \frac{N_t}{N_r} \times \frac{R}{w}

where N_t is the number of microspheres (or radioactivity counts) in the tissue sample, N_r is the number in the reference sample, R is the reference withdrawal rate (mL/min), and w is the tissue weight in grams.^[62] For reliable accuracy within 10% of true values, at least 400 microspheres must be present per tissue sample, necessitating careful dose titration (e.g., 1-5 × 10^6 spheres total) to avoid aggregation or embolization.^[61] Post-experiment, tissues are excised, weighed, and analyzed via gamma scintillation counting for radioactive labels or fluorescence spectroscopy for non-radioactive variants.^[62] This method finds primary applications in animal research for studying regional organ perfusion, such as myocardial blood flow distribution in models of ischemia or hypertension, and in intraoperative cardiac studies during open-heart procedures in experimental settings to assess real-time coronary reserve.^[63] In rodent and canine models, it has enabled detailed mapping of subendocardial versus subepicardial flows, revealing heterogeneity under stress conditions like exercise or pharmacological vasodilation.^[61] Key advantages include high spatial resolution down to samples as small as 50 mg, allowing introrgan perfusion gradients, and the ability to perform multiple sequential measurements (up to 8-13 with distinct labels) in the same subject.^[62] However, it requires animal sacrifice for full analysis in most cases or invasive catheterization in intraoperative use, limiting clinical translation; radiation exposure from isotopes poses handling risks, and uneven distribution can occur if mixing is incomplete.^[61] In the 2020s, there has been a notable shift toward fluorescent microspheres (e.g., polystyrene beads labeled with dyes like yellow-green or crimson), which eliminate radioactivity while maintaining comparable accuracy through automated fluorescence detection, facilitating safer chronic and small-animal studies.^[64]

Nuclear Medicine Approaches

Nuclear medicine approaches to perfusion assessment utilize scintigraphic techniques with radiotracers to evaluate blood flow dynamically in organs such as the heart, providing functional insights into tissue perfusion. These methods involve the intravenous administration of short-lived radioisotopes that distribute according to regional blood flow, followed by imaging to capture tracer uptake and distribution. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are the primary modalities, offering both qualitative and quantitative evaluation of perfusion defects.^[65] A key SPECT technique employs technetium-99m sestamibi (99mTc-sestamibi) for myocardial perfusion imaging, where the tracer is taken up by myocardial cells in proportion to blood flow. In PET, nitrogen-13 ammonia (13N-ammonia) serves as a widely used tracer for quantitative assessment of coronary blood flow, enabling measurement of absolute myocardial blood flow (MBF) values. These tracers are selected for their favorable biodistribution, allowing differentiation between normal and ischemic tissues based on flow-dependent uptake.^[66]^[65] The standard protocol begins with intravenous injection of the radiotracer, typically under rest conditions, followed by imaging using a gamma camera for SPECT or a PET scanner. For 99mTc-sestamibi SPECT, doses range from 8 to 12 mCi at rest, with imaging acquired 30 to 60 minutes post-injection to allow for myocardial uptake; stress imaging (via exercise or pharmacologic agents like adenosine) follows with a higher dose (up to 30-40 mCi) and similar acquisition timing. In 13N-ammonia PET protocols, 10-20 mCi is injected for both rest and stress phases, with dynamic imaging starting immediately after injection to capture the first-pass transit, often completed within 25-60 minutes total. Analysis involves generating time-activity curves from dynamic data to model tracer kinetics and derive perfusion parameters.^[67]^[65] Quantification in these approaches focuses on the uptake rate of the tracer, which correlates directly with blood flow; for instance, 13N-ammonia PET yields absolute MBF in units of mL/g/min, with normal resting values around 0.8-1.2 mL/g/min and stress values exceeding 2.5 mL/g/min indicating preserved flow reserve. In SPECT with 99mTc-sestamibi, semi-quantitative indices like the summed stress score assess relative perfusion, while advanced dynamic protocols enable absolute flow estimation comparable to PET. These metrics provide a robust measure of perfusion heterogeneity, outperforming relative assessments in detecting multivessel disease.^[68]^[69] Clinically, these techniques are applied in stress-rest protocols to detect ischemia, where reduced tracer uptake during stress relative to rest signifies flow-limiting coronary artery disease. For example, 99mTc-sestamibi SPECT identifies reversible perfusion defects with high sensitivity (85-90%) for significant stenoses, guiding revascularization decisions. Similarly, 13N-ammonia PET offers superior accuracy (up to 95%) for quantifying coronary flow reserve, stratifying risk in patients with suspected or known coronary artery disease.^[70]^[71] Despite their efficacy, nuclear medicine perfusion imaging carries limitations, including exposure to ionizing radiation from the radiotracers, with effective doses typically 10-15 mSv for SPECT and 5-10 mSv for PET protocols, necessitating dose optimization strategies. Additionally, spatial resolution is lower (approximately 10-15 mm for SPECT and 4-6 mm for PET) compared to non-ionizing modalities like MRI, potentially limiting detection of small perfusion abnormalities. Access to on-site cyclotrons for 13N-ammonia production further restricts widespread use.^[72]^[73]^[66]

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) provides a non-invasive means to assess tissue perfusion through techniques that exploit changes in magnetic resonance signals influenced by blood flow and contrast agents. Dynamic contrast-enhanced (DCE) MRI involves the intravenous administration of gadolinium-based contrast agents, which alter the T1 relaxation time of blood and tissues, allowing for the mapping of perfusion parameters such as cerebral blood flow (CBF) and blood volume.^[74] This method captures rapid serial images during the first pass of the contrast bolus, enabling quantitative evaluation of microvascular perfusion in various organs.^[75] An alternative non-contrast approach is arterial spin labeling (ASL), which magnetically tags inflowing arterial blood protons as an endogenous tracer to measure perfusion without exogenous agents. In ASL, typically applied to cerebral perfusion, inversion pulses selectively label blood in feeding arteries, and the difference between labeled and control images yields perfusion-weighted signals.^[76] This technique is particularly useful for brain imaging, providing absolute CBF quantification in milliliters per 100 grams per minute, and avoids risks associated with contrast media.^[77] Analysis of MRI perfusion data involves processing time-series signal intensity curves to derive key parameters. In both DCE and ASL methods, deconvolution of tissue signals with an arterial input function informs perfusion metrics, often using adaptations of the Kety model for CBF estimation. These parameters allow for voxel-wise mapping of perfusion heterogeneity, aiding in the identification of ischemic or hyperperfused regions.^[78] In clinical applications, MRI perfusion excels in stroke evaluation by delineating salvageable penumbra through mismatch between diffusion and perfusion deficits, guiding thrombolytic or endovascular therapies.^[79] For tumor angiogenesis, DCE-MRI quantifies vascular permeability and flow, correlating elevated transfer coefficients with neovascularization in gliomas and other malignancies, which informs anti-angiogenic treatment responses.^[80] Key advantages include the absence of ionizing radiation, reducing cumulative exposure risks, and the multi-parametric nature that simultaneously assesses flow, volume, and permeability for comprehensive tissue characterization.^[81] Recent advances in the 2020s have introduced 4D flow MRI, which extends phase-contrast techniques to provide time-resolved, three-dimensional velocity mapping of vascular structures, enhancing perfusion assessment in complex anatomies like the aorta or cerebral arteries. This method facilitates detailed hemodynamic analysis, including wall shear stress and flow vortices, with improved acceleration schemes enabling routine clinical use.^[82]

Computed Tomography

Computed tomography (CT) perfusion imaging is a functional technique that enables rapid, volumetric evaluation of tissue blood flow by tracking the passage of an iodinated contrast agent bolus through the vascular bed. The method involves intravenous injection of a high-concentration iodinated contrast medium, followed by dynamic serial acquisition of CT slices during the arterial phase, typically using bolus-tracking software to initiate scanning once a threshold enhancement is detected in a reference artery. This approach captures time-density curves for arteries, veins, and tissue parenchyma, allowing for the computation of perfusion metrics across multiple slices or volumes in modern multidetector CT systems.^[83] Perfusion parameters are derived from these time-density curves using mathematical deconvolution models, which separate the effects of arterial input and tissue impulse response functions to estimate key hemodynamic values. Central Blood Volume (CBV) quantifies the volume of blood in the tissue microvasculature, Mean Transit Time (MTT) measures the average time for blood to pass through the capillary bed, and Cerebral Blood Flow (CBF) is calculated as the ratio CBF = CBV / MTT, providing an indicator of perfusion rate. These parameters are generated as color-coded maps, with thresholds aiding in the identification of ischemic or hyperperfused regions; for instance, prolonged MTT and reduced CBF are hallmarks of hypoperfusion.^[84]^[85] In clinical practice, CT perfusion is widely applied in acute ischemic stroke triage to delineate salvageable penumbra from infarct core, guiding decisions for thrombolysis or thrombectomy within time-sensitive windows. In oncology, it assesses tumor vascularity and viability, particularly for monitoring treatment response in hepatic, colorectal, or head-and-neck malignancies, where elevated CBF and CBV correlate with aggressive, perfused lesions versus necrotic areas. The technique's high temporal resolution supports whole-brain coverage in under 60 seconds, making it suitable for emergency settings, though it contrasts with MRI's non-ionizing approach preferred in pediatrics.^[83]^[85]^[86] Key advantages include its speed—enabling acquisition in less than one minute—and broad availability on standard CT scanners, facilitating rapid integration into acute workflows without specialized hardware. However, limitations encompass significant radiation exposure, typically ranging from 4 to 15 mSv per study with modern protocols (as of 2025), though older or non-optimized scans may reach up to 20-25 mSv, alongside risks of contrast-induced nephropathy, particularly in patients with renal impairment or dehydration, where incidence may reach 3-5% in emergency contexts. As of 2025, AI-enhanced reconstruction techniques enable ultra-low-dose CT perfusion protocols, reducing effective doses to under 3 mSv while maintaining diagnostic accuracy.^[87] Strategies such as dose-optimized protocols and hydration mitigate these concerns, but careful patient selection remains essential.^[88]^[89]^[90]^[91]

Thermal Diffusion

Thermal diffusion flowmetry, also known as the thermal clearance method, employs a specialized probe to measure local tissue perfusion by quantifying heat dissipation. The probe, typically consisting of two thermistors spaced a few millimeters apart—one serving as a reference to measure baseline tissue temperature and the other actively heated— is inserted into the tissue of interest. Perfusion is inferred from the rate at which blood flow carries away heat from the warmed thermistor, as higher blood flow accelerates cooling and reduces the steady-state temperature difference between the thermistors. This principle relies on the convective heat transfer by blood overriding conductive heat loss in perfused tissues, allowing real-time assessment of microcirculatory blood flow in absolute units such as ml/100 g/min.^[92]^[93] The perfusion value is derived from the thermal conductivity of the tissue, which increases linearly with blood flow rate. A common formulation expresses effective thermal conductivity k_{\text{eff}} as k_{\text{eff}} = k_0 + \beta w, where k_0 is the baseline tissue conductivity without perfusion, \beta is an empirically determined constant, and w is the perfusion rate; the probe measures k_{\text{eff}} via the electrical power P supplied to maintain a fixed temperature offset \Delta T, approximated as k_{\text{eff}} \propto P / \Delta T. Calibration is performed empirically using known flow rates in phantom models or animal tissues to account for variations in tissue properties, ensuring accuracy within 10-20% for specific applications.^[92]^[94] This technique finds primary use in intraoperative monitoring, such as during neurosurgical procedures where the probe is placed in brain parenchyma to track regional cerebral blood flow changes in response to interventions like aneurysm clipping or tumor resection. In critical care settings, it enables continuous bedside surveillance of perfusion in high-risk patients, such as those with traumatic brain injury, to detect ischemia early and guide hemodynamic management. Representative studies have validated its sensitivity, showing rCBF increases from 49 to 120 ml/100 g/min during hypercapnia challenges.^[93]^[95] Key advantages include its ability to provide continuous, quantitative point measurements with high temporal resolution (seconds) and minimal invasiveness relative to larger implants, facilitating integration into multimodal neuromonitoring arrays. However, it is limited to superficial local assessments, typically sampling a volume of 1-2 mm depth around the probe tip, and its readings can be influenced by heterogeneous tissue thermal conductivity and edema, necessitating site-specific calibration.^[92]^[96]

Clinical Applications

Surgical Perfusion

Surgical perfusion refers to the techniques employed during operative procedures to maintain adequate blood flow and oxygenation to tissues and organs, preventing ischemia and supporting physiological functions under controlled conditions. These methods are essential in complex surgeries where normal circulation is interrupted, such as cardiac operations or organ transplantation. Key approaches include cardiopulmonary bypass for systemic support, isolated limb perfusion for localized tumor treatment, and hypothermic machine perfusion for organ preservation, each tailored to specific surgical needs while minimizing complications like inflammation. Cardiopulmonary bypass (CPB) is a cornerstone of cardiac surgery, utilizing an extracorporeal circuit to temporarily take over heart and lung functions. The circuit typically comprises a venous reservoir for blood collection, a centrifugal or roller pump to propel blood, an oxygenator to facilitate gas exchange, a heat exchanger for temperature regulation, and arterial filters to remove debris.^[97]^[98] Standard non-pulsatile flow rates during normothermic CPB are maintained at 2.2-2.4 L/min/m² of body surface area to ensure adequate oxygen delivery, adjusted based on patient hemodynamics and temperature.^[99]^[100] Anticoagulation is achieved primarily with unfractionated heparin, administered at an initial dose of 300-400 IU/kg to maintain activated clotting times above 480 seconds, preventing thrombus formation in the circuit.^[101] Isolated limb perfusion (ILP) is a targeted technique used primarily for treating in-transit metastases of melanoma in the extremities, isolating the limb's circulation to deliver high-dose chemotherapy without systemic exposure. The procedure involves cannulating the major artery and vein, clamping collateral vessels, and perfusing the limb with a warmed solution containing melphalan (typically 10-13 mg/L of limb volume) under mild hyperthermia at 39-40°C for 60-90 minutes, often combined with tumor necrosis factor-alpha to enhance antitumor effects.^[102]^[103]^[104] This hyperthermic approach improves drug penetration and cytotoxicity, achieving complete response rates of approximately 50-70% as reported in clinical studies and meta-analyses for melanoma in-transit metastases.^[105]^[106] In organ transplantation, hypothermic machine perfusion (HMP) preserves kidneys by continuously circulating a cold preservation solution through the renal vasculature, mitigating ischemic damage during ex vivo storage. Performed at 4°C, HMP uses pulsatile or non-pulsatile flows of 1-2 mL/min/g of kidney weight to maintain low vascular resistance and nutrient delivery, reducing the incidence of delayed graft function compared to static cold storage, particularly for extended criteria donors.^[107]^[108] Clinical trials and meta-analyses have demonstrated approximately a 40% relative reduction (OR 0.59-0.70) in delayed graft function rates with HMP, improving one-year graft survival.^[109]^[108] Intraoperative monitoring of perfusion is critical, with near-infrared spectroscopy (NIRS) providing noninvasive assessment of cerebral oxygenation by measuring regional oxygen saturation in the frontal cortex. NIRS detects desaturations below 50% as indicators of inadequate cerebral perfusion, guiding adjustments in CPB flow or blood pressure during cardiac surgery.^[110]^[111] This technique correlates with jugular venous oxygen saturation and has been associated with reduced neurological complications when interventions are applied promptly.^[112] A major complication of CPB is the systemic inflammatory response syndrome (SIRS), triggered by blood-circuit contact, leading to cytokine release, endothelial activation, and potential multi-organ dysfunction. This response affects up to 30% of patients, manifesting as fever, coagulopathy, and prolonged ventilation, with risk factors including prolonged bypass duration and hypothermia.^[113]^[114] Strategies to mitigate SIRS include biocompatible circuit coatings and corticosteroid administration, though outcomes vary.^[115]

Therapeutic Interventions

Therapeutic interventions for perfusion deficits aim to restore or enhance tissue blood flow through non-surgical means, primarily targeting acute and chronic conditions such as shock, ischemia, and vascular insufficiency. These approaches include pharmacological agents that modulate vascular tone, mechanical devices that support cardiac output, adjunctive therapies like hyperbaric oxygen to boost oxygen delivery, and emerging regenerative strategies using stem cells to promote neovascularization. While effective in stabilizing hemodynamics and promoting healing in select cases, outcomes vary, with evidence from randomized trials underscoring the need for patient-specific application to avoid limited or adverse effects.^[116] Pharmacological interventions focus on vasopressors and vasodilators to optimize perfusion pressure and flow. In septic shock, norepinephrine is the first-line vasopressor, recommended to achieve a mean arterial pressure (MAP) target of at least 65 mmHg, as this threshold supports organ perfusion without excessive vasoconstriction. This guideline stems from the Surviving Sepsis Campaign, which emphasizes early initiation to reduce mortality in vasodilatory shock states. Conversely, vasodilators like nitroglycerin are employed in angina pectoris to relieve myocardial ischemia by dilating coronary arteries and reducing preload, thereby improving subendocardial perfusion during episodes of chest pain. Sublingual or intravenous administration provides rapid relief, with guidelines endorsing its use in acute coronary syndromes to balance oxygen supply and demand.^[117]^[116]^[118] Mechanical support, such as the intra-aortic balloon pump (IABP), addresses cardiogenic shock by counterpulsation to augment diastolic coronary perfusion and reduce systolic afterload. The device inflates in the descending aorta during diastole, increasing coronary artery pressure by up to 20-30%, and deflates during systole to lower left ventricular workload. Despite its physiological rationale, clinical evidence from the IABP-SHOCK II trial demonstrated no significant mortality benefit at 30 days or one year in patients with myocardial infarction-related shock, leading to downgraded recommendations in current guidelines against routine use.^[119]^[120] Hyperbaric oxygen therapy (HBOT) enhances perfusion-independent oxygen delivery in hypoxic wounds, particularly diabetic foot ulcers, by increasing plasma-dissolved oxygen to partial pressures of approximately 2000 mmHg at 2-3 atmospheres absolute (ATA). This elevates tissue oxygenation in poorly vascularized areas, promoting angiogenesis, collagen synthesis, and bacterial clearance, with Undersea and Hyperbaric Medical Society guidelines supporting its adjunctive role for Wagner grade 3+ ulcers unresponsive to standard care. Systematic reviews indicate improved healing rates by 20-30% compared to conventional therapy alone, reducing amputation risk in chronic cases.^[121]^[122]^[123] Stem cell therapies, particularly those involving endothelial progenitor cells (EPCs), represent a regenerative approach to enhance perfusion in peripheral artery disease (PAD) by stimulating angiogenesis and arteriogenesis. In 2020s clinical trials, autologous EPCs derived from bone marrow or peripheral blood have been infused to mobilize and differentiate into endothelial cells, improving limb perfusion as measured by ankle-brachial index and transcutaneous oxygen pressure. Phase II studies, such as those reviewed in recent meta-analyses, report modest gains in pain-free walking distance and ulcer healing, though larger randomized trials are needed to confirm long-term efficacy and safety. Recent phase II/III trials as of 2024-2025, including mesenchymal stromal cell therapies like REGENACIP®, continue to report improvements in limb perfusion and ulcer healing in chronic limb-threatening ischemia.^[124]^[125]^[126] Overall outcomes of these interventions highlight variable impacts on mortality and perfusion restoration. For instance, the IABP-SHOCK II trial (2012) found no reduction in 30-day all-cause mortality (39.7% with IABP vs. 41.3% without), despite hemodynamic improvements, influencing a shift toward more targeted mechanical supports like Impella in refractory cases. Pharmacological strategies in sepsis achieve MAP goals in over 80% of patients but do not universally lower mortality without bundled care. HBOT and stem cell approaches show promise for chronic ischemia, with healing rates up to 75% in responsive subgroups, yet cost-effectiveness and accessibility remain challenges.^[120]^[117]^[123]

References

[1]
Perfusion Magnetic Resonance Imaging: A Comprehensive Update ...
Perfusion is a fundamental biological function that refers to the delivery of oxygen and nutrients to tissue by means of blood flow. Perfusion MRI is sensitive ...
[2]
Physiology and measurement of tissue perfusion - PubMed
The concept of tissue perfusion has been aliked with blood flow, oxygen delivery or a combination of flow and nutritional supply including that of oxygen. A ...
[3]
Physiology, Pulmonary Ventilation and Perfusion - StatPearls - NCBI
Ventilation (V) refers to the flow of air into and out of the alveoli, while perfusion (Q) refers to the flow of blood to alveolar capillaries.
[4]
Clinical Perfusion MRI: Techniques and Applications
Mar 1, 2014 · Perfusion MR imaging is now part of clinical practice, mostly for evaluation of cerebrovascular diseases and brain tumors. It also has had a ...
[5]
Cardiovascular Perfusionist - Explore Healthcare Careers
Perfusion is the passage of bodily fluids, such as blood, through the circulatory or lymphatic system to an organ or tissue. Because the heart is mainly ...
[6]
Assessments of Perfusion, Blood Flow, and Vascular Structure in ...
Feb 24, 2023 · There are presently a wide array of techniques and approaches available to investigators wishing to study blood flow, perfusion, and vascular ...
[7]
Perfusion - Etymology, Origin & Meaning
Originating in the 1570s from French and Latin, perfusion means "a pouring through," derived from Latin perfundere, combining roots for "throughout" and "to ...
[8]
The precise physiological definition of tissue perfusion and ...
Apr 2, 2018 · Such weight estimates are bloodless, so the perfusion rate has units of millilitres per minute per gram of bloodless tissue. By dividing Ki ...
[9]
Perfusion (blood flow) - TPC
Apr 7, 2014 · Perfusion is the volume of blood flowing through certain mass (or volume) of tissue per unit time. Blood flow is usually given in units mL/(100 g * min) or mL/ ...
[10]
Difference Between Perfusion and Diffusion
Nov 21, 2017 · The key difference between perfusion and diffusion is, perfusion is the blood flow through a certain mass of the tissue in a unit time whereas, ...
[11]
Physiology, Cardiac Output - StatPearls - NCBI Bookshelf - NIH
Cardiac output is dependent on the heart as well as the circulatory system- veins and arteries. CO is the product of heart rate (HR) by stroke volume (SV), the ...
[12]
Introduction - Control of Cardiac Output - NCBI Bookshelf
The two kidneys each receive about 10% of resting cardiac output, more than what is required to meet the metabolic requirements of their tissues.
[13]
Physiology Tutorial - Cardiovascular Function
The flow to skeletal muscles can dramatically change (flow can increase from 20-70% of total cardiac output) depending on use and thus their metabolic demand.
[14]
Oxygen and nutrient delivery in tissue engineering: Approaches to ...
Under normal physiological conditions, tissues rely on the body's circulatory system to supply individual cells with nutrients and oxygen for their survival, ...
[15]
Cardiopulmonary Fitness - StatPearls - NCBI Bookshelf
VO2 is derived using the Fick equation where maximal oxygen uptake equals cardiac output x the arteriovenous difference (VO2 = CO x (CaO2 – CvO2). Higher ...Missing: principle | Show results with:principle
[16]
Physiology, Vascular - StatPearls - NCBI Bookshelf
May 1, 2023 · The vascular system is responsible for the distribution of oxygen and metabolites, removal of waste materials, and thermoregulation.
[17]
Blood flow distribution in cerebral arteries - PubMed
Mar 31, 2015 · Total cerebral blood flow (717 ± 123 mL/min) was distributed to each side as follows: middle cerebral artery (MCA), 21%; distal MCA, 6%; ...
[18]
Renal perfusion pressure: role and implications in critical illness - PMC
Aug 8, 2025 · The kidneys receive approximately 20–25% of the cardiac output - roughly 1 L per minute of blood flow (Fig. 1). Despite such high blood flow, ...
[19]
Discovery of the cardiovascular system: from Galen to William Harvey
Galen claimed that the liver produced blood that was then distributed to the body in a centrifugal manner, whereas air or pneuma was absorbed from the lung ...
[20]
[PDF] Galen's (130-201 AD) Conceptions of the Heart
However his erroneous theory of blood circulation, based on the inaccurate notion that venous blood passes through tiny pores in the heart's septum, moves from ...
[21]
William Harvey and the Discovery of the Circulation of the Blood
Apr 25, 2019 · In 1628, when Harvey published De Motu Cordis, the medical world was still under the pervasive (and nefarious) influence of Galen, who lived in ...Missing: perfusion | Show results with:perfusion
[22]
William Harvey and the discovery of the circulation of the blood - PMC
This Commentary emphasizes the fundamental contribution of William Harvey to the discovery of the circulation of the blood and his scientific and experimental ...Missing: basis | Show results with:basis
[23]
The discovery of vasomotor nerves | Clinical Autonomic Research
In 1851, Bernard showed that section of the cervical sympathetic nerve unexpectedly elicited a marked and rapid increase in skin temperature. In 1852, Brown- ...
[24]
The discovery of vasomotor nerves - PubMed
The relative contribution of Claude Bernard and Charles Edouard Brown-Séquard to the discovery of vasomotor nerves is described and discussed.
[25]
19th-century anatomical illustration: Part one - ScienceDirect.com
... blood vessels, and lymphatic vessels injected with colored dyes. Tiedemann was one of the first anatomists to begin a systematic study of arterial ...
[26]
fused capillaries of the frog mesentery. - The Physiological Society
When single capillaries in the exposed transilluminated frog mesentery were perfused with solutions containing patent blue V (molecular radius 0 7 nm), ...Missing: visualization | Show results with:visualization
[27]
175th Anniversary of the First Public Demonstration of the Use of ...
Oct 16, 2021 · On October 16, 1846, the first successful public demonstration of the use of ether for surgical anesthesia was performed, making pain-free surgery possible.
[28]
Evolution of Cardiopulmonary Bypass | Circulation
Jun 2, 2009 · The first successful open heart operation using cardiopulmonary bypass was done by John Gibbon on May 6, 1953. The operation was closure of an ...
[29]
John H. Gibbon, Jr. Part I. The development of the first ... - PubMed
Finally, on May 6, 1953, Dr. Gibbon performed his first successful operation using an extracorporeal circuit on an 18-year-old woman with a large atrial septal ...
[30]
CT Perfusion: Technical Developments and Current and Future ...
The official history of Computed Tomography perfusion (CTp) began in 1979 when Heinz and his colleagues published their paper [1].
[31]
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.108.830174
[32]
Successful ex-vivo normothermic machine perfusion and... - LWW
This study shows that normothermic machine perfusion of human donor livers is feasible and offers a great future perspective. Normothermic perfusion of ECD ...
[33]
A Phase 1 (First-in-Man) Clinical Trial - PubMed
We present the first patients transplanted using a normothermic machine perfusion (NMP) device that transports and stores an organ in a fully functioning state ...
[34]
Blood Vessels and Endothelial Cells - Molecular Biology of ... - NCBI
Endothelial cells form a single cell layer that lines all blood vessels and regulates exchanges between the bloodstream and the surrounding tissues.
[35]
Capillary Fluid Exchange - NCBI Bookshelf - NIH
Capillary fluid exchange is the partition of fluid between vascular and interstitial compartments, regulated by forces and allowing for tissue turnover and ...
[36]
Regulation of Vascular Tone and Oxygenation - NCBI - NIH
Precapillary sphincters regulate the diffusive delivery of oxygen to cells/tissues by modulating the number of perfused capillaries. The number of perfused ...
[37]
Structural and functional aspects of liver sinusoidal endothelial cell ...
The liver sinusoids can be regarded as unique capillaries which differ from other capillaries in the body, because of the presence of open pores or fenestrae ...
[38]
Phenotypic Heterogeneity of the Endothelium | Circulation Research
Feb 2, 2007 · Endothelial cells, which form the inner cellular lining of blood vessels and lymphatics, display remarkable heterogeneity in structure and function.
[39]
The endothelial glycocalyx: composition, functions, and visualization
The endothelial glycocalyx is a network of membrane-bound proteoglycans and glycoproteins, covering the endothelium luminally.
[40]
https://www.ahajournals.org/doi/10.1161/01.res.0000255690.03436.ae
[41]
Myocardial ischemia: lack of coronary blood flow, myocardial ... - NIH
Myocardial ischemia is defined as an imbalance between supply (of oxygen or of coronary blood flow) and demand (largely for contractile function).
[42]
The Penn Classification System for Malperfusion in Acute Type A ...
Nov 2, 2022 · Patients are assigned to Penn class on the basis of total body burden of malperfusion—none, local, global, or combined local and global. Penn ...
[43]
Malperfusion Syndromes in Aortic Dissection - PMC - PubMed Central
Feb 8, 2016 · Malperfusion syndrome results from end-organ ischemia in the setting of an aortic dissection. Malperfusion can affect nearly all major ...
[44]
Insights From the International Registry of Acute Aortic Dissection
Apr 24, 2018 · Acute aortic dissection (AAD) is a life-threatening condition associated with high morbidity and mortality rates, and it remains a challenge ...Missing: global | Show results with:global<|control11|><|separator|>
[45]
Cell Biology of Ischemia/Reperfusion Injury - PMC - PubMed Central
During prolonged ischemia, ATP levels and intracellular pH decrease as a result of anaerobic metabolism and lactate accumulation. As a consequence, ATPase- ...
[46]
Lactic Acidosis - StatPearls - NCBI Bookshelf - NIH
Apr 28, 2025 · The condition is defined by a serum lactate concentration above 4 mmol/L, often accompanied by a blood pH below 7.35 and low plasma bicarbonate ...
[47]
Postcarotid Endarterectomy Hyperperfusion or Reperfusion Syndrome
Dec 2, 2004 · Hyperperfusion syndrome (HS) after carotid endarterectomy (CEA) has been related to impaired cerebrovascular autoregulation in a chronically hypoperfused ...Missing: malperfusion | Show results with:malperfusion
[48]
Cardiovascular Disease - StatPearls - NCBI Bookshelf - NIH
Coronary artery disease (CAD): Sometimes referred to as Coronary Heart Disease (CHD), results from decreased myocardial perfusion that causes angina, myocardial ...
[49]
Coronary Artery Spasm: From Physiopathology to Diagnosis - PMC
The main risk factors are the classical risk factors for coronary artery disease (CAD), including age, smoking status, high LDL cholesterol levels, arterial ...4. Normal Coronary... · 5. Coronary Spasm And... · 6.1. Vsmcs...
[50]
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid ...
Jun 28, 2016 · Acute ICA occlusion leads to a regional decrease in cerebral perfusion pressure, which may not only hamper middle cerebral artery (MCA) clot ...
[51]
Heart Failure (Congestive Heart Failure) - StatPearls - NCBI Bookshelf
Feb 26, 2025 · A decrease in cardiac output stimulates the neuroendocrine system by releasing epinephrine, norepinephrine, endothelin-1 (ET-1), and vasopressin ...
[52]
Hypovolemia and Hypovolemic Shock - StatPearls - NCBI Bookshelf
Jun 1, 2025 · Hypovolemia leads to inadequate tissue perfusion and hypoxia and can quickly progress to organ dysfunction or failure if not promptly addressed.
[53]
Distributive Shock - StatPearls - NCBI Bookshelf - NIH
Distributive shock as a result of sepsis occurs due to a dysregulated immune response to infection that leads to systemic cytokine release and resultant ...
[54]
Multiple Organ Dysfunction Syndrome - PubMed
"(3) There are many risk factors predisposing to MODS; however, the most common risk factors are shock due to any cause, sepsis, and tissue hypoperfusion. A ...
[55]
Brain tissue responses to ischemia - PMC - PubMed Central - NIH
Complete interruption of blood flow to the brain for only 5 minutes triggers the death of vulnerable neurons in several brain regions, whereas 20–40 minutes of ...
[56]
Multiple Organ Dysfunction Syndrome in Humans and Animals - PMC
Multiple organ dysfunction syndrome (MODS) is defined as “the presence of altered organ function in an acutely ill patient such that homeostasis cannot be ...Missing: timelines | Show results with:timelines
[57]
Free radical-mediated reperfusion injury: a selective review - PMC
... injury is caused by toxic oxygen metabolites that are generated from xanthine oxidase at the time of reperfusion. This mechanism was first identified and ...
[58]
The role of oxidants and free radicals in reperfusion injury - PubMed
May 1, 2006 · Under ischemic conditions, xanthine oxidase can reduce nitrite to generate NO. NO and peroxynitrite can inhibit pathways of oxygen radical ...
[59]
The history of the microsphere method for measuring blood flows ...
Apr 1, 2017 · The two dyes require dissolving the tissue, cleaning up the microspheres, and then eluting the dyes for measurement, which must be done with ...
[60]
Blood flow distributions by microsphere deposition methods - PMC
Microsphere methods provide information on regional perfusion between and within organs that is more detailed than that from flow probes. They are also easier ...
[61]
Development of a novel protocol for processing fluorescent ...
Aug 23, 2025 · Current methods for measuring perfusion use fluorescent polystyrene microspheres (MS) that are systemically injected prior to processing to ...
[62]
SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0
Aug 1, 2013 · MPI (13N-ammonia or 82Rb) and myocardial metabolic imaging (18F-FDG) can be performed using PET (6). Details of 13N-ammonia imaging protocols ...
[63]
Cardiac PET Perfusion Tracers: Current Status and Future Directions
Availability of these tracers is limited by need for an on-site (15O water and 13N ammonia) or nearby (13N ammonia) cyclotron or commitment to costly generators ...
[64]
Procedure Guideline for Myocardial Perfusion Imaging 3.3
Patients should be fasting before rest myocardial perfusion imaging for at least 4 h. Cardiac medications should be withheld if the examination is performed to ...
[65]
Quantitative myocardial perfusion SPECT/CT for the assessment of ...
Absolute quantification of myocardial tracer uptake is feasible. The method seems to be robust and principally suitable for routine clinical reporting.
[66]
Myocardial blood flow and myocardial flow reserve values in 13N ...
Jun 11, 2018 · This study established flow values for 13 NH 3 myocardial PET/CT with a time-efficient protocol, and established that MBF in stress corrected for residual ...
[67]
Myocardial Perfusion Scan - StatPearls - NCBI Bookshelf - NIH
Nov 18, 2024 · Myocardial perfusion scanning refers to a group of noninvasive imaging tests that help clinicians assess blood flow to the myocardium.Missing: definition | Show results with:definition
[68]
Diagnostic accuracy of 13N-ammonia myocardial perfusion imaging ...
The main finding of our study was that 13N-ammonia PET-MPI has high diagnostic accuracy for the detection of coronary artery stenosis of more than 50%; in ...
[69]
[PDF] Recommendations for Reducing Radiation Exposure in Myocardial ...
Administered radiation dose may vary considerably based on patient weight and charac- teristics of the imaging system. There are a number of approaches ...
[70]
Approaches to Reducing Radiation Dose from Radionuclide ...
Apr 1, 2015 · This paper provides a practical approach to performing low-radiation-dose MPI using traditional and novel technologies.
[71]
Dynamic contrast-enhanced magnetic resonance imaging
DCE-MRI possesses an unparalleled capacity to quantitatively measure not only perfusion but also other diverse microvascular parameters such as vessel ...
[72]
Dynamic Contrast-Enhanced MRI and Its Applications in Various ...
Dec 31, 2022 · DCE-MRI is a noninvasive imaging technique used to evaluate tissue vascularity/permeability features through consecutive imaging acquisitions.Dce-Mri · Brain Tumors · Neurodegenerative Disease
[73]
Arterial Spin Labeling: Techniques, Clinical Applications, and ...
Nov 11, 2022 · Arterial spin labeling is an emerging noninvasive MRI technique for assessing cerebral perfusion that uses magnetically labeled arterial water protons in blood.
[74]
Arterial spin labeling in neuroimaging - PMC - PubMed Central
Arterial spin labeling (ASL) is a magnetic resonance imaging technique for measuring tissue perfusion using a freely diffusible intrinsic tracer.
[75]
Perfusion MR Imaging: Evolution from Initial Development to ... - NIH
Perfusion MRI is currently an effective tool to non-invasively quantify cerebral blood flow ... Kety's first-order washout decay model (Kety 1949) and its ...
[76]
Review of Perfusion Imaging in Acute Ischemic Stroke
Feb 3, 2020 · In acute ischemic stroke, perfusion imaging may increase diagnostic accuracy, aid treatment target identification, and provide prognostic ...
[77]
Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging ...
We conclude that DCE MRI perfusion parameters are potential imaging biomarkers for prediction of tumor angiogenesis and aggressiveness.
[78]
Revolutionizing vascular imaging: trends and future directions of 4D ...
Jan 18, 2024 · 4D flow MRI is a promising new technology with potential clinical value in hemodynamic quantification.
[79]
Theoretic Basis and Technical Implementations of CT Perfusion in ...
CT perfusion (CTP) is a functional imaging technique that provides important information about capillary-level hemodynamics of the brain parenchyma.
[80]
Deconvolution-Based CT and MR Brain Perfusion Measurement
CT perfusion parameter maps of cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time-to-peak (TTP). The ischemic stroke ...
[81]
Perfusion CT in Acute Ischemic Stroke: A Qualitative and ...
Quantitative perfusion parameters such as CBF, CBV, TTP, MTT, and TTD can be calculated and displayed as color maps. Indications for reperfusion therapy may be ...
[82]
CT Perfusion of the Liver: Principles and Applications in Oncology
CT perfusion imaging is a promising technique for diagnosing primary or metastatic tumors, for assessing the efficacy of systemic or local tumor therapy.
[83]
Narrative review of cardiac computed tomography perfusion - NIH
Myocardial CT perfusion (CTP) can be achieved with a single static ... In this review we will discuss the technique with its advantages and limitations.
[84]
Advances in myocardial CT perfusion imaging technology - PMC - NIH
The limitations and direction of developments in CTP technology · Artifacts · Radiation dose · Contrast agents.
[85]
Radiation exposure in perfusion CT of the brain - PubMed
Results: The thermoluminescent dosimeter measurements yielded effective doses of 3.8 mSv (80 kV), 8.6 mSv (100 kV), 14.1 mSv (120 kV), and 22.2 mSv (140 kV).
[86]
Contrast-induced nephropathy: A dilemma between loss of neurons ...
An incidence of 3–5% has been reported in patients undergoing emergency CT perfusion/CT angiography (CTP/CTA) for acute ischemia. In patients with mild to ...
[87]
A Phantom Tissue System for the Calibration of Perfusion ... - NIH
A TDP uses a self-heated thermistor to measure absolute perfusion in real time by measuring the power required to keep the probe temperature higher than the ...
[88]
Continuous monitoring of regional cerebral blood flow: experimental ...
Current clinical neuromonitoring techniques lack adequate surveillance of cerebral perfusion. In this article, a novel thermal diffusion (TD) microprobe is ...
[89]
Non-Invasive Blood Perfusion Measurements Using a Combined ...
A thermal diffusion probe uses a self-heated thermistor to measure the power as a function of time required to keep the probe temperature a constant offset ...
[90]
Continuous monitoring of regional cerebral blood flow - PubMed
A novel thermal diffusion (TD) microprobe is evaluated for the continuous and quantitative assessment of intraparenchymal regional cerebral blood flow (rCBF).Missing: seminal | Show results with:seminal
[91]
Thermal Diffusion - an overview | ScienceDirect Topics
Insertion of a thermal diffusion probe on surface of the brain allows CBF to be calculated from the temperature difference between the plates. Thermal diffusion ...Missing: formula | Show results with:formula
[92]
Basics of cardiopulmonary bypass - PMC - PubMed Central - NIH
It incorporates an extracorporeal circuit to provide physiological support in which venous blood is drained to a reservoir, oxygenated and sent back to the body ...Missing: m2 | Show results with:m2
[93]
Basics of cardiopulmonary bypass - Indian Journal of Anaesthesia
CPB circuit includes pumps, cannulae, tubing, reservoir, oxygenator, heat exchanger and arterial line filter [Figure 1]. Modern CPB machines have systems for ...Missing: m2 | Show results with:m2
[94]
[PDF] Cardiopulmonary Bypass for the Anaesthetist
Aug 2, 2024 · The cardiac index of a 70 kg adult at 37°C is 2.2–2.4 L/m2/min. Pump flow rate = BSA × Cardiac index. An activated clotting time (ACT) test ...
[95]
Optimal Perfusion Flow Rates for Cardiopulmonary Bypass
In retrospect, McGoon's recommended flow rate of 2.2 to 2.4l/m2/min allows oxygen uptake in the range of 130 ml/min/m2. (Lewin 46). This is within the range ...Missing: m²/ | Show results with:m²/
[96]
Anticoagulation for cardiopulmonary bypass: part one - PMC
Extracorporeal circulation requires adequate anticoagulation to prevent catastrophic clot formation within the oxygenator, circuit failure, or both. •.Missing: 2.2-2.4 m2
[97]
Hyperthermic isolated limb perfusion for recurrent melanomas and ...
All patients underwent a 90-min isolated limb perfusion with melphalan (10 mg/l limb volume) and TNF-alpha (1-2 mg) under mild hyperthermia (39-40 degrees C).
[98]
Isolated Limb Perfusion of Upper Limb: How I Do It - PubMed Central
The ILP consists of 90-min-long perfusion with 13 mg/L volume of melphalan at mild hyperthermia (39–40 °C). We use water displacement method to measure the ...Isolated Limb Perfusion Of... · Ilp Procedure · Fig. 1
[99]
A retrospective comparative study evaluating the results of mild ...
The aim of this study was to investigate the role of mild hyperthermia (39-40 degrees C) in isolated cytostatic perfusion for patients with recurrent ...
[100]
One Hundred Consecutive Isolated Limb Perfusions With TNF-α and ...
Melphalan-based ILP for melanoma IT-metastases is associated with complete response (CR) rates of 40% to 50% and overall response rates of 75% to 80%.Patients And Methods · Local Progression · Survival
[101]
Long and Short-Term Effects of Hypothermic Machine Perfusion vs ...
Aug 25, 2023 · Hypothermic machine perfusion (HMP) has been shown to reduce delayed graft function (DGF)-rates in kidneys from expanded criteria donors (ECD) ...
[102]
Machine preservation of donor kidneys in transplantation - PMC - NIH
Hypothermic machine perfusion reduces delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis.
[103]
Beneficial Effect of Moderately Increasing Hypothermic Machine ...
Vascular resistance and flow rate during hypothermic machine perfusion (HMP) of kidneys is correlated with graft function. We aimed to determine the effects ...
[104]
Clinical Applications of Near-Infrared Spectroscopy Monitoring In ...
Near-infrared spectroscopy monitoring provides a practical method to follow trends in superficial cerebral cortex oxygenation during and after cardiovascular ...
[105]
Cerebral oxygenation monitoring using near infrared spectroscopy ...
Near infrared spectroscopy (NIRS), otherwise known as cerebral oximetry, is a non-invasive device that uses infrared light to estimate brain tissue oxygenation ...
[106]
Cerebral near‐infrared spectroscopy (NIRS) for perioperative ...
We assessed the effects of monitoring the brain with cerebral near‐infrared spectroscopy (NIRS), and treatments based on it, during and after surgery in adults ...
[107]
Narrative review of the systemic inflammatory reaction to cardiac ...
Cardiac surgery and cardiopulmonary bypass still provoke a systemic inflammatory response, which occasionally leads to worsened outcome.
[108]
Systemic inflammation and cardiac surgery: an update - PubMed
Cardiac surgery with cardiopulmonary bypass (CPB) is associated with the development of a systemic inflammatory response that can often lead to dysfunction ...
[109]
Prevalence and Clinical Impact of Systemic Inflammatory Reaction ...
Cardiac surgery induces a systemic inflammatory reaction that has been associated with postoperative mortality and morbidity.
[110]
Nitroglycerin - StatPearls - NCBI Bookshelf
Nitroglycerin is a vasodilatory drug used primarily to provide relief from anginal chest pain. It is currently FDA approved for the acute relief of an attack.
[111]
Surviving Sepsis Campaign Guidelines 2021 | SCCM
Oct 3, 2021 · For adults with septic shock on vasopressors, we recommend an initial target mean arterial pressure (MAP) of 65 mm Hg over higher MAP targets.
[112]
Nitrates in the management of acute coronary syndrome - UpToDate
May 26, 2023 · SUMMARY AND RECOMMENDATIONS · INTRODUCTION · MECHANISMS OF ACTION · SIDE EFFECTS AND CAUTION · SUBLINGUAL NITROGLYCERIN · INTRAVENOUS NITROGLYCERIN.
[113]
Intra-aortic Balloon Pump - AATS
An IABP sits in the descending thoracic aorta and works to decrease ventricular afterload, positively augment diastolic pressure and subsequently improve end- ...
[114]
Intraaortic Balloon Support for Myocardial Infarction with ...
Aug 27, 2012 · In current international guidelines, intraaortic balloon counterpulsation is considered to be a class I treatment for cardiogenic shock ...
[115]
Therapeutic effects of hyperbaric oxygen: integrated review - LWW
During the HBOT procedure, the oxygen pressure in arterial blood can increase to 2000 mmHg (~266.6 kPa), and the high blood-to-tissue oxygen pressure gradient ...
[116]
[PDF] A clinical practice guideline for the use of hyperbaric oxygen therapy ...
BACkgRound: The role of hyperbaric oxygen (HBO2) for the treatment of diabetic foot ulcers (DFUs) has been examined in the medical literature for decades.
[117]
Diabetic foot ulcers treated with hyperbaric oxygen therapy: a review ...
Hyperbaric oxygen therapy (HBO) has been used as an adjunct for healing diabetic foot ulcers (DFUs) for decades. However, its use remains controversial.
[118]
Vascular regeneration in peripheral artery disease - PMC - NIH
Asahara's discovery of “endothelial progenitor cells” (EPCs) in 1997 galvanized interest in adult stem cells for vascular regeneration. These cells originate in ...Peripheral Arterial Disease... · Angiogenic Cytokines · Nonstandard Abbreviations...
[119]
Editorial: Recent Advances in Endothelial Progenitor Cells Toward ...
They concluded that EPCs used in clinical trials were highly heterogeneous cell populations and highlighted the need for better-defined cell populations such as ...